Evidence map›Paper›PMID 29626235›Full record

ReviewApplied microbiology and biotechnology2018

The CRISPR/Cas9 system sheds new lights on the biology of protozoan parasites.

Maciej Grzybek, Aleksandra Golonko, Aleksandra Górska, Klaudiusz Szczepaniak, Aneta Strachecka, Anna Lass, Paweł Lisowski

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Glycosomal Phosphoenolpyruvate Carboxykinase CRISPR/Cas9-Deletion and Its Role in Trypanosoma cruzi Metacyclogenesis and Infectivity in Mammalian Host.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. The CRISPR-Cas9 System inMicroorganisms · 2025
    Article
  4. Applications of CRISPR in Parasitology.Current pharmaceutical biotechnology · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Editing the microbiome the CRISPR way.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Maciej GrzybekDepartment of Tropical Parasitology, Medical University of Gdansk, Powstania Styczniowego 9b, 81-519, Gdynia, Poland. grzybek.genetics@gmail.com.ORCID http://orcid.org/0000-0002-8780-0304
Aleksandra GolonkoDepartment of Biotechnology, Bialystok University of Technology, Wiejska 45E, 15-351, Bialystok, Poland.
Aleksandra GórskaFaculty of Veterinary Medicine, University of Life Sciences in Lublin, Akademicka 13, 20-950, Lublin, Poland.
Klaudiusz SzczepaniakFaculty of Veterinary Medicine, University of Life Sciences in Lublin, Akademicka 13, 20-950, Lublin, Poland.
Aneta StracheckaFaculty of Biology, Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, Akademicka 13, 20-950, Lublin, Poland.
Anna LassDepartment of Tropical Parasitology, Medical University of Gdansk, Powstania Styczniowego 9b, 81-519, Gdynia, Poland.
Paweł LisowskiDepartment of Molecular Biology, Institute of Genetics and Animal Breeding PAS, Postepu 36A, 05-552, Jastrzebiec, Poland.
University of Life Sciences in Lublin · PLGdańsk Medical University · PLBialystok University of Technology · PLMax Delbrück Center · DE

Funding

Ministerstwo Nauki i Szkolnictwa Wyższego 428/STYP/11/2016Narodowe Centrum Nauki 2012/07/N/NZ9/02060Narodowe Centrum Nauki 2016/22/M/NZ2/00548
6 · The paper itself

Abstract

The CRISPR/Cas9 system, a natural defence system of bacterial organisms, has recently been used to modify genomes of the most important protozoa parasites. Successful genome manipulations with the CRISPR/Cas9 system are changing the present view of genetics in parasitology. The application of this system offers a major chance to overcome the current restriction in culturing, maintaining and analysing protozoan parasites, and allows dynamic analysis of parasite genes functions, leading to a better understanding of pathogenesis. CRISPR/Cas9 system will have a significant influence on the process of developing novel drugs and treatment strategies against protozoa parasites.

Indexed as

CRISPR-Cas SystemsAnimalsEukaryotaGenome, ProtozoanParasitesApicomplexaCas9CRISPRGenetic modificationGenome editingProtozoa

Identifiers

PMID29626235
PMCPMC5954013
OpenAlexW2795830584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.